Gains and limitations of predictive rules for severe community-acquired Pneumonia

Clinical Infectious Diseases

Volumn 53, Issue 6, 2011, Pages 512-514

  Ewig, Santiago ^a  

^a Augusta Kranken Anstalt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM;

COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; PATIENT ADMISSION; PNEUMONIA;

EID: 80052218956     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir469     Document Type: Note

References (16)

1. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26:1138-80. (Pubitemid 41829947)
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-72. (Pubitemid 46290553)
3. LimWS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64(Suppl 3):Siii1-55.
4. Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med 2011; 37:214-23.
5. Chalmers JD, Taylor JK, Mandal P, et al. Validation of the IDSA/ATS minor criteria for ICU admission in community-acquired pneumonia patients without major criteria or contraindications to ICU care. Clin Infect Dis 2011; 53:509-17.
6. Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64:1062-9.
7. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54. (Pubitemid 32578779)
8. España PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174:1249-56. (Pubitemid 44924826)
9. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375-84. (Pubitemid 352009359)
10. Phua J, See KC, Chan YH, et al. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009; 64:598-603.
11. Renaud B, Labarère J, Coma E, et al. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care 2009; 13:R54.
12. Ramirez P, Ferrer M, Marti V, et al. Inflammatory biomarkers and prediction of ICU admission in severe communityacquired pneumonia. Crit Care Med 2011. [Epub ahead of print].
13. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006; 129:968-78.
14. Ewig S, Torres A. Community-acquired pneumonia as an emergency. Eur Respir J 2011. [Epub ahead of print].
15. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
16. Ewig S, Torres A. Severe community-acquired pneumonia. Clin Chest Med 1999; 20:575-87. (Pubitemid 29466246)